CLL Stock Overview
A privately owned investment manager. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CLR Investment Fund Public Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.003 |
| 52 Week High | €0.008 |
| 52 Week Low | €0.0015 |
| Beta | 0.13 |
| 11 Month Change | 20.00% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 33 Year Change | 50.00% |
| 5 Year Change | 50.00% |
| Change since IPO | -99.48% |
Recent News & Updates
What CLR Investment Fund Public Ltd.'s (CSE:CLL) 40% Share Price Gain Is Not Telling You
Nov 18
More Unpleasant Surprises Could Be In Store For CLR Investment Fund Public Ltd.'s (CSE:CLL) Shares After Tumbling 29%
Oct 04Shareholder Returns
| CLL | CY Capital Markets | CY Market | |
|---|---|---|---|
| 7D | 20.0% | -0.9% | 0.8% |
| 1Y | 0% | 140.3% | 54.1% |
Return vs Industry: CLL underperformed the CY Capital Markets industry which returned 144.3% over the past year.
Return vs Market: CLL underperformed the CY Market which returned 54.5% over the past year.
Price Volatility
| CLL volatility | |
|---|---|
| CLL Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 6.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in CY Market | 7.7% |
| 10% least volatile stocks in CY Market | 2.3% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine CLL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.clr-investment.com |
CLR Investment Fund Public Ltd. is a privately owned investment manager. The firm invests in the public equity markets.
CLR Investment Fund Public Ltd. Fundamentals Summary
| CLL fundamental statistics | |
|---|---|
| Market cap | €864.42k |
| Earnings (TTM) | €60.55k |
| Revenue (TTM) | €266.57k |
14.3x
P/E Ratio3.2x
P/S RatioIs CLL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLL income statement (TTM) | |
|---|---|
| Revenue | €266.57k |
| Cost of Revenue | €0 |
| Gross Profit | €266.57k |
| Other Expenses | €206.02k |
| Earnings | €60.55k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00021 |
| Gross Margin | 100.00% |
| Net Profit Margin | 22.71% |
| Debt/Equity Ratio | 23.7% |
How did CLL perform over the long term?
See historical performance and comparison